FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for bromocriptine mesylate from Zydus Pharmaceuticals USA Inc., resulting in labeling changes for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Hyperprolactinemia
• Parkinson Disease

Drugs mentioned

• Bromocriptine mesylate (bromocriptine mesylate)

Snippet

SUPPL AP for BROMOCRIPTINE MESYLATE (BROMOCRIPTINE MESYLATE)